BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11435574)

  • 21. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
    Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
    J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide.
    Truong MJ; Delsart V; Bahr GM
    Virus Res; 2004 Jan; 99(1):25-33. PubMed ID: 14687943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
    Yoshida A; Tanaka R; Murakami T; Takahashi Y; Koyanagi Y; Nakamura M; Ito M; Yamamoto N; Tanaka Y
    J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
    AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
    Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
    J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes.
    García M; Yu XF; Griffin DE; Moss WJ
    J Gen Virol; 2008 Apr; 89(Pt 4):984-993. PubMed ID: 18343840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic induction of apoptosis in primary CD4(+) T cells by macrophage-tropic HIV-1 and TGF-beta1.
    Wang J; Guan E; Roderiquez G; Norcross MA
    J Immunol; 2001 Sep; 167(6):3360-6. PubMed ID: 11544326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands.
    Ghezzi S; Menzo S; Brambilla A; Bordignon PP; Lorini AL; Clementi M; Poli G; Vicenzi E
    Virology; 2001 Feb; 280(2):253-61. PubMed ID: 11162839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.
    Poles MA; Elliott J; Taing P; Anton PA; Chen IS
    J Virol; 2001 Sep; 75(18):8390-9. PubMed ID: 11507184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.
    Zou W; Denton PW; Watkins RL; Krisko JF; Nochi T; Foster JL; Garcia JV
    Retrovirology; 2012 May; 9():44. PubMed ID: 22640559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.
    Picchio GR; Gulizia RJ; Wehrly K; Chesebro B; Mosier DE
    J Virol; 1998 Mar; 72(3):2002-9. PubMed ID: 9499054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide.
    Vidal V; Dewulf J; Bahr GM
    Immunology; 2001 Aug; 103(4):479-87. PubMed ID: 11529939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
    Wang FX; Xu Y; Sullivan J; Souder E; Argyris EG; Acheampong EA; Fisher J; Sierra M; Thomson MM; Najera R; Frank I; Kulkosky J; Pomerantz RJ; Nunnari G
    J Clin Invest; 2005 Jan; 115(1):128-37. PubMed ID: 15630452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.
    Lin YL; Portales P; Segondy M; Baillat V; de Boever CM; Le Moing V; Réant B; Montes B; Clot J; Reynes J; Corbeau P
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):530-6. PubMed ID: 16044003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
    Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
    J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins disrupt CCR5 and RANTES expression levels in CD4(+) T lymphocytes in vitro and preferentially decrease infection of R5 versus X4 HIV-1.
    Nabatov AA; Pollakis G; Linnemann T; Paxton WA; de Baar MP
    PLoS One; 2007 May; 2(5):e470. PubMed ID: 17520029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.